Richard Preston
Clinical Pharmacology · Miami, FLNPI 1972535011
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$10,185,949in research payments, 2019–2025
Across 230 payments — averaging $44,287 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3M
- Vertex$2.4M
- Bristol Myers Squibb$1.5M
- Takeda Pharmaceuticals U.S.A., Inc.$845K
- AbbVie$589K
- Mitsubishi Tanabe Pharma Development America, Inc.$537K
- plus $1.4M from 7 others
How this compares
Too few clinical pharmacology providers in Floridato place this figure against a meaningful peer group, so we don't.
Other clinical pharmacology in Miami
- Kenneth LasseterHialeah$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.